RecruitingNot ApplicableNCT06225830

Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton

Utilization of Robotic EksoSkeleton to Achieve High Dosing, Intensity, and Complexity of Gait in Treatment of People With Parkinson's Disease


Sponsor

Albert Einstein Healthcare Network

Enrollment

24 participants

Start Date

Jun 4, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this study is to see how well therapy with the Eksobionic Exoskeleton (Esko) works for people with Parkinson's disease (PWPD). Esko is a robotic device that provides high repetition and intensity training. The investigators will examine its impact on walking, balance, and quality of life before, during and after an eight-week intervention program. The results will lay the groundwork for future trials, potentially leading to long-term improvements in mobility and quality of life for PWPD.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a robotic exoskeleton (EksoSkeleton) — a wearable device that helps support and guide leg movements — can improve walking ability and balance in people with Parkinson's disease when used as part of intensive physical therapy sessions. **You may be eligible if...** - You have been diagnosed with idiopathic Parkinson's disease (Parkinson's not caused by another condition) - You are over 18 years old - You have self-reported walking or balance difficulties - You can tolerate at least 15 minutes of standing upright - You weigh 220 pounds (100 kg) or less - You are approximately between 5'0" and 6'4" tall - You can straighten your knees and have near-normal hip and ankle movement - You are able to use a front-wheeled walker with your arms **You may NOT be eligible if...** - You are currently enrolled in another rehabilitation study or therapy program - You have another neurological disease - You have a significant leg length difference, spinal instability, or severe bone fracture history - You have open skin sores where the exoskeleton would contact your body - You are pregnant - You have had a change in your Parkinson's medications in the past week - You have severe uncontrolled low blood pressure when standing Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEEksobionics Eksoskeleton NR

During treatment sessions, the therapist will guide the participant's progress using a specific plan. The therapist will set a trajectory for each leg, determining the appropriate step height and length, and program it into the Ekso device. The Ekso will then assist the participant by following this trajectory, with varying levels of assistance for each step. As the participant improves, the therapist will gradually reduce the assistance provided until the participant reaches a point where they no longer require assistance or reach a plateau. In the final phase, the trajectory will be removed, and the participant will walk using their own movements. The therapist may add resistance or assistance based on the participant's needs, but it will be in line with their self-generated movements rather than a predetermined path.


Locations(1)

Jefferson Moss-Magee Rehabilitation - Elkins Park

Elkins Park, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06225830


Related Trials